Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B

Martina Musella, Andrea Guarracino, Nicoletta Manduca, Claudia Galassi, Eliana Ruggiero, Alessia Potenza, Ester Maccafeo, Gwenola Manic, Luca Mattiello, Sara Soliman Abdel Rehim, Michele Signore, Marco Pietrosanto, Manuela Helmer-Citterich, Matteo Pallocca, Maurizio Fanciulli, Tiziana Bruno, Francesca De Nicola, Giacomo Corleone, Anna Di Benedetto, Cristiana ErcolaniEdoardo Pescarmona, Laura Pizzuti, Francesco Guidi, Francesca Sperati, Sara Vitale, Daniele Macchia, Massimo Spada, Giovanna Schiavoni, Fabrizio Mattei, Adele De Ninno, Luca Businaro, Valeria Lucarini, Laura Bracci, Eleonora Aricò, Giovanna Ziccheddu, Francesco Facchiano, Stefania Rossi, Massimo Sanchez, Alessandra Boe, Mauro Biffoni, Ruggero De Maria Marchiano^*, Ilio Vitale^*, Antonella Sistigu^*

^*Corresponding author

Department of Medicine and Translational Surgery
Faculty of Medicine and Surgery
Academic Field: Pathology and Laboratory Medicine

University of Rome Tor Vergata
San Raffaele Scientific Institute
IIGM-Italian Institute for Genomic Medicine
Istituto Superiore di Sanita
IRCCS Istituti fisioterapici ospitalieri - Istituto Regina Elena
IRCCS Istituto Dermatologico Santa Maria e San Gallicano – Roma
National Research Council of Italy
IRCCS Ospedale pediatrico Bambino Gesù - Roma

Research output: Contribution to journal › Article

Sort by
Weight
Alphabetically

Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B

Fingerprint

Medicine and Dentistry